 SAN DIEGO, July 06, 2021 GLOBE NEWSWIRE -- Metacrine, Inc. NASDAQ:MTCR, a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal diseases, today announced that it will present new preclinical data at the European Crohns and Colitis Organisation ECCO 2021 Virtual Congress on July 9, 2021. 